Ubs Group Ag Repligen Corp Transaction History
Ubs Group Ag
- $528 Billion
- Q1 2025
A detailed history of Ubs Group Ag transactions in Repligen Corp stock. As of the latest transaction made, Ubs Group Ag holds 241,074 shares of RGEN stock, worth $28.5 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
241,074
Previous 188,811
27.68%
Holding current value
$28.5 Million
Previous $27.2 Million
12.87%
% of portfolio
0.01%
Previous 0.01%
Shares
33 transactions
Others Institutions Holding RGEN
# of Institutions
494Shares Held
57.6MCall Options Held
75.6KPut Options Held
521K-
Black Rock Inc. New York, NY7.57MShares$894 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.57MShares$893 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$600 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$199 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.67MShares$198 Million0.04% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $6.55B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....